DR HOENLE AG (HNL.DE) Stock Price, Quote, News and Overview
FRA:HNL - Deutsche Boerse Ag - DE0005157101 - Common Stock - Currency: EUR
HNL.DE Quote, Performance and Key Statistics
FRA:HNL (5/9/2025, 7:00:00 PM)
10
+0.32 (+3.31%)
The current stock price of HNL.DE is 10 EUR. In the past month the price increased by 17.92%. In the past year, price decreased by -48.72%.
HNL.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SND.DE | SCHNEIDER ELECTRIC SE | 25.84 | 123.73B | ||
| SU.PA | SCHNEIDER ELECTRIC SE | 25.82 | 123.65B | ||
| LR.PA | LEGRAND SA | 24.89 | 27.02B | ||
| PRY.MI | PRYSMIAN SPA | 20.94 | 15.61B | ||
| NXS.DE | NEXANS SA | 13.82 | 4.34B | ||
| NEX.PA | NEXANS SA | 13.71 | 4.30B | ||
| LIGHT.AS | SIGNIFY NV | 7 | 2.51B | ||
| G14.DE | SIGNIFY NV | 7 | 2.51B | ||
| CENER.BR | CENERGY HOLDINGS SA | 16.12 | 1.92B | ||
| ZAP.OL | ZAPTEC ASA | N/A | 1.72B | ||
| TWEKA.AS | TKH GROUP NV-DUTCH CERT | 14.55 | 1.54B | ||
| CMB.MI | CEMBRE SPA | 14.54 | 892.50M |
Related stock screener links
About HNL.DE
Company Profile
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet products. The company is headquartered in Gilching, Bayern and currently employs 585 full-time employees. The company went IPO on 2008-02-25. The firm is engaged in three business units (BU): Adhesive Systems, Curing and Disinfection. The Adhesive Systems BU supplies industrial adhesives and Ultra-Violet (UV) light curing equipment for the electronics, medical technology, optics, and automotive sectors. The Curing BU sells equipment and installations for curing paints and coatings, these systems facilitate printers (particularly packaging printers), in surface coatings for floor coverings, in the furniture industry, in the automotive industry and in other industrial coating applications. The company also offers lifecycle solutions. The Disinfection BU combines the business activities in the areas of water, surface, and air disinfection. The Disinfection segment also offers services such as microbiological analysis in addition to UV lamps and components. The firm operates globally with around 20 subsidiaries.
Company Info
DR HOENLE AG
Nicolaus-Otto-Str. 2
Gilching BAYERN DE
Employees: 585
Phone: 49810520830
DR HOENLE AG / HNL.DE FAQ
What is the stock price of DR HOENLE AG today?
The current stock price of HNL.DE is 10 EUR. The price increased by 3.31% in the last trading session.
What is the ticker symbol for DR HOENLE AG stock?
The exchange symbol of DR HOENLE AG is HNL and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is HNL.DE stock listed?
HNL.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for DR HOENLE AG stock?
6 analysts have analysed HNL.DE and the average price target is 19.89 EUR. This implies a price increase of 98.9% is expected in the next year compared to the current price of 10. Check the DR HOENLE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DR HOENLE AG worth?
DR HOENLE AG (HNL.DE) has a market capitalization of 60.60M EUR. This makes HNL.DE a Micro Cap stock.
How many employees does DR HOENLE AG have?
DR HOENLE AG (HNL.DE) currently has 585 employees.
What are the support and resistance levels for DR HOENLE AG (HNL.DE) stock?
DR HOENLE AG (HNL.DE) has a support level at 8.46 and a resistance level at 10.01. Check the full technical report for a detailed analysis of HNL.DE support and resistance levels.
Is DR HOENLE AG (HNL.DE) expected to grow?
The Revenue of DR HOENLE AG (HNL.DE) is expected to grow by 4.63% in the next year. Check the estimates tab for more information on the HNL.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DR HOENLE AG (HNL.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HNL.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HNL.DE, evaluating the profitability, health, valuation and growth aspects
- DR HOENLE AG (HNL.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DR HOENLE AG (HNL.DE) Sales and EPS estimates to see what analysts future expectations are.
- DR HOENLE AG (HNL.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DR HOENLE AG (HNL.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- DR HOENLE AG (HNL.DE) Stock Chart to make your own analysis
- DR HOENLE AG (HNL.DE) Latest news and press-releases to stay up to date.
Does DR HOENLE AG (HNL.DE) stock pay dividends?
HNL.DE does not pay a dividend.
When does DR HOENLE AG (HNL.DE) report earnings?
DR HOENLE AG (HNL.DE) will report earnings on 2025-05-08.
What is the Price/Earnings (PE) ratio of DR HOENLE AG (HNL.DE)?
DR HOENLE AG (HNL.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.14).
HNL.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to HNL.DE. When comparing the yearly performance of all stocks, HNL.DE is a bad performer in the overall market: 91.83% of all stocks are doing better.
HNL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HNL.DE. Both the profitability and financial health of HNL.DE have multiple concerns.
HNL.DE Financial Highlights
Over the last trailing twelve months HNL.DE reported a non-GAAP Earnings per Share(EPS) of -2.14. The EPS decreased by -8.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.45% | ||
| ROE | -16.43% | ||
| Debt/Equity | 0.48 |
HNL.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HNL.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 105.88% and a revenue growth 4.63% for HNL.DE